Q32 Bio (QTTB) Other Non Operating Income (2017 - 2026)

Q32 Bio's Other Non Operating Income history runs 10 years deep, the most recent figure standing at $113000.0 for Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 90.56% year-over-year to $113000.0 in Q1 2026; TTM through Mar 2026 was $97000.0, a 98.12% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 71.35% from the prior year.
• Other Non Operating Income slipped to $113000.0 in Q1 2026 per QTTB's latest filing, from $114000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $131.3 million in Q1 2022 and bottomed at -$119.1 million in Q4 2022.
• The 5-year median for Other Non Operating Income is $196000.0 (2023), against an average of $1.2 million.
• Biggest YoY gain for Other Non Operating Income was 345376.32% in 2022; the steepest drop was 1453.52% in 2022.
• Year by year, Other Non Operating Income stood at -$119.1 million in 2022, then soared by 100.16% to $196000.0 in 2023, then surged by 82.65% to $358000.0 in 2024, then plunged by 68.16% to $114000.0 in 2025, then fell by 0.88% to $113000.0 in 2026.
• Per Business Quant, the three latest QTTB Other Non Operating Income figures stand at $113000.0 (Q1 2026), $114000.0 (Q4 2025), and $188000.0 (Q3 2025).